HR Execs on the Move

Lumicks

www.lumicks.com

 
LUMICKS is the leading supplier of Dynamic Single-Molecule and Cell Avidity analysis instruments` Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells` Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail` Our goal is to improve human health by unlocking the power of Dynamic Single–Molecule and Cell Avidity analysis to provide unparalleled insight into the fundamental cause ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.lumicks.com
  • 800 South Street Suite 100
    Waltham, MA USA 02453
  • Phone: 781.366.0380

Executives

Name Title Contact Details

Similar Companies

Aderans Research Institute

Aderans Research Institute is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scios

Scios Inc. is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

NATURAL STATE LABORATORIES

Caprion Proteomics

Caprion Proteomics Inc. is a Gatineau, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Artiva Biotherapeutics

Artiva Biotherapeutics is a private biotech company advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. Artiva Biotherapeutics was founded on the understanding that NK cells hold enormous therapeutic potential as cancer therapies and the dedication and expertise to overcome technological barriers in the scaling and manufacturing of these cells. At Artiva, our mission is to deliver highly effective cell therapies that are also safe and immediately available and accessible to any cancer patient who stands to benefit. Artiva`s platform delivers scalability, quality, and cryopreservation to support a pipeline of safe, effective, versatile, and accessible product candidates.